Selinexor
This page contains brief information about selinexor and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
FDA label information for this drug is available at DailyMed.
Use in Cancer
Selinexor is approved to treat:
- Multiple myeloma. It is used:
- With bortezomib and dexamethasone in adults who have received at least one treatment.
- With dexamethasone in adults whose disease has come back or did not respond after at least four treatments that included at least two proteasome inhibitors, at least two immunomodulating agents, and an anti-CD38 monoclonal antibody.
Selinexor is also being studied in the treatment of other types of cancer.
More About Selinexor
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Selinexor - A lay language summary of important information about this drug.
Research Results and Related Resources
Targeted Therapy to Treat Cancer
Clinical Trials Accepting Patients
Find Clinical Trials for Selinexor - Check for trials from NCI's list of cancer clinical trials now accepting patients.